Showing results (371-380 of 391) with videos related to
Sort By:
Pageof 40
Oncology and Therapy|March 14, 2024
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist PerspectivesLuca Bertolaccini, Andrea De Giglio, Eleonora Gariazzo, et al.Oncology and Therapy|September 27, 2024
Sacituzumab Govitecan for Second and Subsequent Line Palliative Treatment of Patients with Triple-Negative Breast Cancer: A Polish Real-World Multicenter Cohort StudyMiroslawa Püsküllüoğlu, Małgorzata Pieniążek, Manuela Las-Jankowska, et al.Oncology and Therapy|November 16, 2023
Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung CancerGiulio Metro, Eleonora Gariazzo, Silvia Costabile, et al.Oncology and Therapy|October 7, 2023
A Meta-analysis of Surgical Outcomes of T4a and Infranotch T4b Oral CancersKarthik Nagaraja Rao, Ripudaman Arora, Prajwal Dange, et al.Oncology and Therapy|June 26, 2023
Small-Cell Carcinoma of the Prostate - Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective PieceTrish Abbott, Kenrick Ng, Jenny Nobes, et al.Oncology and Therapy|June 4, 2023
Extrapolation of Survival Data Using a Bayesian Approach: A Case Study Leveraging External Data from Cilta-Cel Therapy in Multiple MyelomaStephen Palmer, Yi Lin, Thomas G Martin, et al.Oncology and Therapy|June 6, 2023
Patient and Healthcare Professional Perspectives from ESMO 2022 on Bladder and Kidney Cancer: A PodcastAlex Filicevas, Thomas PowlesOncology and Therapy|September 29, 2023
Shared Decision-Making on Using a CDK4/6 Inhibitor plus an Aromatase Inhibitor for HR+/HER2- Metastatic Breast Cancer: A PodcastBrian Dong, Rita Lusen, Ella Chick, et al.Oncology and Therapy|March 4, 2026
Exploring Patient Perspectives on Upper Tract Urothelial Cancer: A Qualitative Interview StudyDina Filipenko, Michael Acquadro, Ola Ghatnekar, et al.Oncology and Therapy|February 21, 2026
Neoadjuvant Therapy in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer: Recent Progress, Challenges, and Future Directions in the Era of TAR-200 and Enfortumab Vedotin Plus PembrolizumabGiuseppe Di Lorenzo, Massimo Di Maio, Carlo BuonerbaPageof 40